Y0001841

Hydroxychloroquine for system suitability

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): Hydroxychloroquinsulfat -sulfat, 7-Chlor-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]chinolinsulfat
• Empirische Formel (Hill-System): C₁₈H₂₆ClN₃O · H₂SO₄
• CAS-Nummer: 747-36-4
• Molekulargewicht: 433.95
• EG-Nummer: 212-019-3
• MDL-Nummer: MFCD00078203
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• API-Familie: hydroxychloroquine
• Lagertemp.: 2-8°C
• SMILES String: OS(O)(=O)=O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
• InChI: 1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)
• InChIKey: JCBIVZZPXRZKTI-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Biochem./physiol. Wirkung

Hydroxychloroquinsulfat ist ein entzündungshemmendes (über TNF), krankheitsmodifizierendes Antirheumatikum (DMARD) und ein Hemmstoff der Hämpolymerase. Es wird bei der Behandlung von Malaria eingesetzt.

Verpackung

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302,H315,H319
• P-Sätze: P301 + P312 + P330 - P305 + P351 + P338
• Gefahreneinstufungen: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable